LifeScan

Diabetes Management Apps Market to Record an Exponential CAGR of 24.4% by 2031 - Exclusive Report by InsightAce Analytic

Retrieved on: 
Tuesday, December 5, 2023
Hypertension, Type of service, Prevalence, Insulin, Type, Tablet, Roche, Patient, Health, Subscription business model, LifeScan, Person, Growth, Diabetes, Pharmaceutical industry, Medical device

North America is anticipated to be the major contributor to the Diabetes Management Apps market over the forecast years.

Key Points: 
  • North America is anticipated to be the major contributor to the Diabetes Management Apps market over the forecast years.
  • In addition, the Asia Pacific Diabetes Management Apps market is expected to grow significantly during the forecast period.
  • Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1310
    Global Diabetes Management Apps Market, by Subscription Model, 2023-2031 (Value US$ Mn)
    Global Diabetes Management Apps Market, by Type of Service, 2023-2031 (Value US$ Mn)
    Global Diabetes Management Apps Market, by O.S.
  • Platform, 2023-2031 (Value US$ Mn)
    Global Diabetes Management Apps Market, by Region, 2023-2031 (Value US$ Mn)

Diabetes Management Apps Market to Record an Exponential CAGR of 24.4% by 2031 - Exclusive Report by InsightAce Analytic

Retrieved on: 
Tuesday, December 5, 2023
Hypertension, Type of service, Prevalence, Insulin, Type, Tablet, Roche, Patient, Health, Subscription business model, LifeScan, Person, Growth, Diabetes, Pharmaceutical industry, Medical device

North America is anticipated to be the major contributor to the Diabetes Management Apps market over the forecast years.

Key Points: 
  • North America is anticipated to be the major contributor to the Diabetes Management Apps market over the forecast years.
  • In addition, the Asia Pacific Diabetes Management Apps market is expected to grow significantly during the forecast period.
  • Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1310
    Global Diabetes Management Apps Market, by Subscription Model, 2023-2031 (Value US$ Mn)
    Global Diabetes Management Apps Market, by Type of Service, 2023-2031 (Value US$ Mn)
    Global Diabetes Management Apps Market, by O.S.
  • Platform, 2023-2031 (Value US$ Mn)
    Global Diabetes Management Apps Market, by Region, 2023-2031 (Value US$ Mn)

Avantor® Names R. Brent Jones as Chief Financial Officer

Retrieved on: 
Thursday, July 13, 2023
Avantor, LifeScan, Growth, Accounting, Blood, AVTR, NYSE, Management

Over a nearly 30-year career, Mr. Jones has served as chief financial officer for several public and private life sciences companies and, previously, as a senior investment banker.

Key Points: 
  • Over a nearly 30-year career, Mr. Jones has served as chief financial officer for several public and private life sciences companies and, previously, as a senior investment banker.
  • He is currently Executive Vice President, Chief Financial Officer and Chief Operating Officer at LifeScan Global Corporation, a global leader in blood glucose monitoring and digital health technology, where he is responsible for all aspects of LifeScan's global finance and operations functions.
  • As Chief Financial Officer and a member of Avantor's Executive Leadership Team, Mr. Jones will lead Avantor's global finance organization and financial activities including accounting and controllership, financial planning and analysis, tax, investor relations, internal audit, and treasury.
  • Thomas A. Szlosek, Avantor's current Chief Financial Officer will serve in such position through August 4, 2023, at which time he will begin a new role outside the life sciences industry.

Glucose Monitoring Devices Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 32.6 Billion by 2028: Verified Market Research®

Retrieved on: 
Tuesday, July 4, 2023
LifeScan, Omron, Diabetes, Dexcom, COVID-19, Power-on self-test, Ageing, Research, USD, App Store (iOS/iPadOS), Incidence, Medtronic, Blood, Patient, Geography, Magnetic resonance, Growth, Medical device, Hospital, Bayer, Application

JERSEY CITY, N.J., July 4, 2023 /PRNewswire/ -- The Global Glucose Monitoring Devices Market is projected to grow at a CAGR of 11.8% from 2021 to 2028, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 14.9 Billion in 2020 and is expected to reach USD 32.6 Billion by the end of the forecast period.

Key Points: 
  • The " Global Glucose Monitoring Devices Market Size By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By Application (Clinics, Hospitals), By Geographic Scope And Forecast " report has been published by Verified Market Research®.
  • The report provides an in-depth analysis of the global Glucose Monitoring Devices Market, including its growth prospects, market trends, and market challenges.
  • For further information, detailed market insights, and a comprehensive analysis of the Global Glucose Monitoring Devices Market, please Contact Verified Market Research ®.
  • Based on the research, Verified Market Research® has segmented the global Glucose Monitoring Devices Market into Product, Application, And Geography.

Digital Diabetes Management Market worth $31.3 billion | MarketsandMarkets

Retrieved on: 
Tuesday, June 20, 2023
CGM, SME, Telehealth, LifeScan, Laboratory, Travel, Diabetes, Patient satisfaction, Abbott, Social support, Abbott Laboratories, COVID-19, Medicine, Quality of life, Beato, Tandem Diabetes Care, App Store (iOS/iPadOS), Patient, Investment, Algorithm, Glooko, Roche, Michael Porter, Motivation, Digital, Self-management, Support, Education, Pharmaceutical industry, Hospital, Cryptocurrency, Medical device, Dexcom, Medtronic

Digital Diabetes Management Market Advantages:

Key Points: 
  • Digital Diabetes Management Market Advantages:
    Improved Monitoring: Digital diabetes management solutions, such as wearable devices and continuous glucose monitoring systems, provide real-time and continuous monitoring of blood glucose levels.
  • Personalized Recommendations: Advanced algorithms and machine learning techniques enable digital diabetes management solutions to analyze individual data and provide personalized recommendations.
  • Cost-Effectiveness: Digital diabetes management has the potential to reduce healthcare costs associated with diabetes management.
  • Additional points in the market overview have been added, keeping in mind the impact of COVID-19 on the overall digital diabetes management market.

Digital Diabetes Management Market worth $31.3 billion | MarketsandMarkets

Retrieved on: 
Tuesday, June 20, 2023
CGM, SME, Telehealth, LifeScan, Laboratory, Travel, Diabetes, Patient satisfaction, Abbott, Social support, Abbott Laboratories, COVID-19, Medicine, Quality of life, Beato, Tandem Diabetes Care, App Store (iOS/iPadOS), Patient, Investment, Algorithm, Glooko, Roche, Michael Porter, Motivation, Digital, Self-management, Support, Education, Pharmaceutical industry, Hospital, Cryptocurrency, Medical device, Dexcom, Medtronic

Digital Diabetes Management Market Advantages:

Key Points: 
  • Digital Diabetes Management Market Advantages:
    Improved Monitoring: Digital diabetes management solutions, such as wearable devices and continuous glucose monitoring systems, provide real-time and continuous monitoring of blood glucose levels.
  • Personalized Recommendations: Advanced algorithms and machine learning techniques enable digital diabetes management solutions to analyze individual data and provide personalized recommendations.
  • Cost-Effectiveness: Digital diabetes management has the potential to reduce healthcare costs associated with diabetes management.
  • Additional points in the market overview have been added, keeping in mind the impact of COVID-19 on the overall digital diabetes management market.

Results from New Study of Real-World Evidence Showing People with Type 2 Diabetes Achieved Clinically Significant Improved Glycemic Control with One to Two Blood Glucose Checks Per Day Using a Smart Blood Glucose Meter and Mobile App Published in Diabetes

Retrieved on: 
Thursday, May 18, 2023
Real-World Evidence, LifeScan, DTT, Diabetes, Glucose, Research, OTR, OTVR, Blood, Data, Global Medical Device Nomenclature, Ageing, Therapy, Abbreviation, Anonymous social media, Medical device, Safety

MALVERN, Pa., May 18, 2023 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring, today announced that results from the study of real-world evidence Sustained Improvements in Readings In-Range Using an Advanced Bluetooth® Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence from more than 55,000 People with Diabetes have been published in the peer-reviewed journal Diabetes Therapy.  A smaller subset of these results was first published in the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) in June, 2022. This new analysis focuses on changes over 180 days given that sustained outcomes for people with diabetes are more clinically relevant.

Key Points: 
  • A smaller subset of these results was first published in the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) in June, 2022.
  • This new analysis focuses on changes over 180 days given that sustained outcomes for people with diabetes are more clinically relevant.
  • These findings warrant further research about how age and the degree of engagement with a smart blood glucose meter and mobile app affect glycemic outcomes.
  • Abbreviations: PwT1D, people with type 1 diabetes; PwT2D, people with type 2 diabetes.

Tandem Diabetes Care Appoints New Chair of Board of Directors

Retrieved on: 
Wednesday, February 22, 2023
Diabetes, Health, Medical Devices, Chemical engineering, Senior, Tandem Diabetes Care, BS, Growth, Face, General partnership, Egis, LifeScan, Cornell University, Pharmaceutical industry, Management, Chiron Corporation, Chiron, Tandem, Versant

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rebecca Robertson as Chair of its Board of Directors.

Key Points: 
  • Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rebecca Robertson as Chair of its Board of Directors.
  • Ms. Robertson, who joined Tandem’s Board as an independent director in January 2019, succeeds Kim Blickenstaff, who will continue as a member of the Board.
  • “We’re deeply grateful to Kim for his instrumental contributions to Tandem since 2007, serving first as our CEO then as Chair for the past 4 years,” said John Sheridan, President and Chief Executive Officer.
  • In addition, through Longridge Business Advisors, she has provided business advisory services and board services since April 2017.

Study Results Published in Journal of Diabetes Science and Technology Show Sustained Clinically Significant Improvements in Glycemic Control in Over 144,000 People with Diabetes Using a Smart Blood Glucose Meter and Mobile App

Retrieved on: 
Tuesday, January 31, 2023
Real-World Evidence, Glycemia, OneTouch Ultra, Overalls, Mobile diabetes screening initiative, American Diabetes Association, Diabetes, Glucose meter, Global Medical Device Nomenclature, Journal of Diabetes Science and Technology, Metre, Smartphone, Blood, LifeScan, Patient, Data, BGM, Research, Medical device, Satellite navigation device, Mobile phone, Limestone, Safety, T1D

The full publication is available with open access at: Journal of Diabetes Science and Technology (JDST), Improved Glycemic Control Using a Bluetooth®-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes .

Key Points: 
  • The full publication is available with open access at: Journal of Diabetes Science and Technology (JDST), Improved Glycemic Control Using a Bluetooth®-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes .
  • These 180-day findings expand on the results from a 90-day timeframe first presented at the 82nd Scientific Sessions of the American Diabetes Association in June 2022.
  • The real-world data provides insights into improved glycemic metrics among people with diabetes using a Bluetooth connected BGM together with a diabetes management digital app - in this study, patients used the OneTouch Verio Flex® meter and OneTouch Reveal® app.
  • "The overwhelming majority, approximately 95%, of people with diabetes who monitor their blood glucose rely on cost-effective blood glucose monitoring with a blood glucose meter.

Digital Diabetes Management Market Size to Reach USD 37.8 Billion in 2030 | Emergen Research

Retrieved on: 
Wednesday, December 21, 2022
Digital technology, Data visualization, USD, World Health Organization, CGMS-A, Patient, Cyberattack, WHO, Diabetes, Obesity, Health, Dexcom, Roche, Digital, Eli Lilly and Company, Medtronic, Partnership, Growth, Zur Rose Group, Risk, DPP, Country, National Association Medical Staff Services, Prescription, Prevalence, Eating, Bayer, DM, Incidence, LifeScan, ICT, Medical device, Pharmaceutical industry

VANCOUVER, B.C., Dec. 21, 2022 /PRNewswire/ -- The digital diabetes management market size reached USD 13.6 Billion in 2021 and is expected to register a CAGR of 12.0% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, B.C., Dec. 21, 2022 /PRNewswire/ -- The digital diabetes management market size reached USD 13.6 Billion in 2021 and is expected to register a CAGR of 12.0% during the forecast period, according to latest analysis by Emergen Research .
  • As a result, the management and treatment of many diseases are depending on the widespread use of information and communication technology (ICT)-based digital health systems, which is driving the adoption of digital diabetes management services in the market.
  • Demand for digital diabetes management devices has significantly increased over the years due to the increasing prevalence of diabetes and obesity around the world.
  • The digital diabetes management market is expected to register a CAGR of 12.0% over the forecast period and revenue is projected to increase from USD 13.6 Billion in 2021 to USD 37.8 Billion in 2030.